Prelude Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,935
| Closed | -$336K | – | 1236 |
|
|
2024
Q1 | $336K | Buy |
3,935
+743
| +23% | +$63.4K | 0.02% | 753 |
|
|
2023
Q4 | $273K | Sell |
3,192
-1,450
| -31% | -$124K | 0.02% | 672 |
|
|
2023
Q3 | $416K | Buy |
+4,642
| New | +$416K | 0.03% | 438 |
|
|
2022
Q2 | – | Sell |
-8,857
| Closed | -$560K | – | 1665 |
|
|
2022
Q1 | $560K | Buy |
+8,857
| New | +$560K | 0.02% | 641 |
|
|
2021
Q4 | – | Sell |
-13,352
| Closed | -$943K | – | 1729 |
|
|
2021
Q3 | $943K | Sell |
13,352
-2,341
| -15% | -$165K | 0.02% | 433 |
|
|
2021
Q2 | $1.05M | Sell |
15,693
-7,204
| -31% | -$480K | 0.03% | 454 |
|
|
2021
Q1 | $2.54M | Buy |
22,897
+5,569
| +32% | +$618K | 0.07% | 137 |
|
|
2020
Q4 | $2.06M | Buy |
17,328
+12,091
| +231% | +$1.44M | 0.05% | 116 |
|
|
2020
Q3 | $457K | Buy |
5,237
+506
| +11% | +$44.2K | 0.02% | 304 |
|
|
2020
Q2 | $424K | Buy |
+4,731
| New | +$424K | 0.02% | 317 |
|
|
2020
Q1 | – | Sell |
-111
| Closed | -$13K | – | 1180 |
|
|
2019
Q4 | $13K | Buy |
+111
| New | +$13K | ﹤0.01% | 1214 |
|
|
2016
Q3 | – | Sell |
-4,362
| Closed | -$126K | – | 1601 |
|
|
2016
Q2 | $126K | Buy |
+4,362
| New | +$126K | 0.02% | 624 |
|
|
2015
Q2 | – | Sell |
-1,605
| Closed | -$72K | – | 1724 |
|
|
2015
Q1 | $72K | Buy |
+1,605
| New | +$72K | 0.01% | 1104 |
|